{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:58:50Z","timestamp":1793699930473,"version":"4.5.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bbi.2023.06.023","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T21:12:33Z","timestamp":1688764353000},"page":"166-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneity"],"prefix":"10.1016","volume":"113","author":[{"given":"Paris","family":"Alexandros Lalousis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne","family":"Schmaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"L.E.P Reniers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L.","family":"Cropley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Pantelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Suckling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Pariante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.E.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Lawrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Dazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Deakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Shannon Weickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Upthegrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbi.2023.06.023_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat Rev Neurosci."},{"issue":"10","key":"10.1016\/j.bbi.2023.06.023_b0010","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/0004867417715914","article-title":"Ventricular volumes across stages of schizophrenia and other psychoses","volume":"51","author":"Berger","year":"2017","journal-title":"Aust N Z J Psychiatry."},{"issue":"1","key":"10.1016\/j.bbi.2023.06.023_b0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-0962-y","article-title":"Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder","volume":"14","author":"Boerrigter","year":"2017","journal-title":"J Neuroinflammation."},{"key":"10.1016\/j.bbi.2023.06.023_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2017.00221","article-title":"Interleukin-6 in schizophrenia\u2014is there a therapeutic relevance?","volume":"8","author":"Borovcanin","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbi.2023.06.023_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577813","article-title":"Maternal immune activation with high molecular weight poly(I:C) in Wistar rats leads to elevated immune cell chemoattractants","volume":"364","author":"Brown","year":"2022","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.bbi.2023.06.023_b0030","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/schbul\/sbw029","article-title":"Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset","volume":"42","author":"Bulzacka","year":"2016","journal-title":"Schizophr Bull."},{"issue":"1","key":"10.1016\/j.bbi.2023.06.023_b0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S0033291705005969","article-title":"The diagnostic interview for psychoses (DIP): development, reliability and applications","volume":"36","author":"Castle","year":"2006","journal-title":"Psychol Med."},{"issue":"8","key":"10.1016\/j.bbi.2023.06.023_b0040","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41386-021-00980-0","article-title":"Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: a longitudinal, randomised, triple-blind placebo-controlled mri study","volume":"46","author":"Chopra","year":"2021","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2023.06.023_b0045","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fncel.2020.00274","article-title":"The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation","volume":"14","author":"Comer","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2023.06.023_b0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S2045796014000341","article-title":"Using longitudinal imaging to map the \u2018relapse signature\u2019 of schizophrenia and other psychoses","volume":"23","author":"Cropley","year":"2014","journal-title":"Epidemiol Psychiatr Sci."},{"issue":"11","key":"10.1016\/j.bbi.2023.06.023_b0055","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2215-0366(18)30345-6","article-title":"The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial","volume":"5","author":"Deakin","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2023.06.023_b0060","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/schbul\/sby164","article-title":"Schizophrenia is associated with an aberrant immune response to epstein-barr virus","volume":"45","author":"Dickerson","year":"2019","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.bbi.2023.06.023_b0065","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mp.2015.168","article-title":"Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression","volume":"21","author":"Felger","year":"2016","journal-title":"Mol Psychiatry."},{"issue":"2","key":"10.1016\/j.bbi.2023.06.023_b0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mp.2012.110","article-title":"Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia","volume":"18","author":"Fillman","year":"2013","journal-title":"Mol. Psychiatry."},{"issue":"8","key":"10.1016\/j.bbi.2023.06.023_b0075","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/mp.2015.90","article-title":"Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca\u2019s area volume","volume":"21","author":"Fillman","year":"2016","journal-title":"Mol Psychiatry."},{"key":"10.1016\/j.bbi.2023.06.023_b0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fpsyt.2020.00160","article-title":"The role of inflammation in the treatment of schizophrenia","volume":"11","author":"Fond","year":"2020","journal-title":"Front Psychiatry."},{"issue":"5","key":"10.1016\/j.bbi.2023.06.023_b0085","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sbn025","article-title":"Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology","volume":"35","author":"Fornito","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2023.06.023_b0090","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbi.2019.06.037","article-title":"Natural killer cells protect white matter integrity in bipolar disorder","volume":"81","author":"Furlan","year":"2019","journal-title":"Brain Behav Immun."},{"issue":"1","key":"10.1016\/j.bbi.2023.06.023_b0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0920-9964(00)00015-3","article-title":"Brain and ventricle instability during psychotic episodes of the schizophrenias","volume":"44","author":"Garver","year":"2000","journal-title":"Schizophr Res."},{"issue":"3","key":"10.1016\/j.bbi.2023.06.023_b0100","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.neuropharm.2011.05.011","article-title":"Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia","volume":"62","author":"Grace","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2023.06.023_b0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbi.2021.11.019","article-title":"Inflammatory subtypes in antipsychotic-na\u00efve first-episode schizophrenia are associated with altered brain morphology and topological organization","volume":"100","author":"Hoang","year":"2022","journal-title":"Brain Behav Immun."},{"issue":"4","key":"10.1016\/j.bbi.2023.06.023_b0110","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1080\/10618600.2014.948179","article-title":"Statistical significance of clustering using soft thresholding","volume":"24","author":"Huang","year":"2015","journal-title":"J Comput Graph Stat."},{"issue":"1","key":"10.1016\/j.bbi.2023.06.023_b0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01908075","article-title":"Comparing partitions","volume":"2","author":"Hubert","year":"1985","journal-title":"J. Classif."},{"issue":"2","key":"10.1016\/j.bbi.2023.06.023_b0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/j.1440-1614.2000.00728.x","article-title":"Psychotic disorders in urban areas: an overview of the study on low prevalence disorders","volume":"34","author":"Jablensky","year":"2000","journal-title":"Aust N Z J Psychiatry."},{"key":"10.1016\/j.bbi.2023.06.023_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02230","article-title":"C-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls","volume":"9","author":"Jacomb","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2023.06.023_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-016-0769-x","article-title":"The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis","volume":"16","author":"Johnsen","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2023.06.023_b0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull."},{"issue":"3","key":"10.1016\/j.bbi.2023.06.023_b0140","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2023.06.023_b0145","series-title":"Encyclopedia of Clinical Neuropsychology","first-page":"2667","year":"2011"},{"key":"10.1016\/j.bbi.2023.06.023_b0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbi.2021.04.002","article-title":"Brain morphology is differentially impacted by peripheral cytokines in schizophrenia-spectrum disorder","volume":"95","author":"Laskaris","year":"2021","journal-title":"Brain Behav Immun."},{"issue":"1","key":"10.1016\/j.bbi.2023.06.023_b0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1197-2","article-title":"Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms","volume":"15","author":"Lesh","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.bbi.2023.06.023_b0160","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/s41386-019-0346-3","article-title":"Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder","volume":"44","author":"Li","year":"2019","journal-title":"Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.bbi.2023.06.023_b0165","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/appi.ajp.2019.18070825","article-title":"Association of choroid plexus enlargement with cognitive, inflammatory, and structural phenotypes across the psychosis spectrum","volume":"176","author":"Lizano","year":"2019","journal-title":"Am J Psychiatry."},{"issue":"7","key":"10.1016\/j.bbi.2023.06.023_b0170","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1038\/s41380-020-00914-0","article-title":"Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis","volume":"26","author":"Lizano","year":"2021","journal-title":"Mol Psychiatry."},{"issue":"11","key":"10.1016\/j.bbi.2023.06.023_b0175","first-page":"1029","article-title":"Australian schizophrenia research bank: a database of comprehensive clinical, endophenotypic and genetic data for aetiological studies of schizophrenia","volume":"44","author":"Loughland","year":"2010","journal-title":"Aust N Z J Psychiatry."},{"issue":"11","key":"10.1016\/j.bbi.2023.06.023_b0180","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.3390\/jcm10112488","article-title":"A meta-Analysis of the influence of antipsychotics on cytokines levels in first episode psychosis","volume":"10","author":"Marcinowicz","year":"2021","journal-title":"J Clin Med."},{"key":"10.1016\/j.bbi.2023.06.023_b0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbi.2016.09.008","article-title":"Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study","volume":"59","author":"Metcalf","year":"2017","journal-title":"Brain Behav Immun."},{"issue":"7","key":"10.1016\/j.bbi.2023.06.023_b0190","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol Psychiatry."},{"issue":"4","key":"10.1016\/j.bbi.2023.06.023_b0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3371\/CSRP.MICU.020813","article-title":"C-reactive protein levels in schizophrenia: a review and meta-analysis","volume":"7","author":"Miller","year":"2014","journal-title":"Clin Schizophr Relat Psychoses."},{"key":"10.1016\/j.bbi.2023.06.023_b0200","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2017.04.015","article-title":"Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: a systematic review","volume":"192","author":"Misiak","year":"2018","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.bbi.2023.06.023_b0205","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4172\/2155-9899.1000479","article-title":"The Major histocompatibility complex (MHC) in schizophrenia: a review","volume":"7","author":"Mokhtari","year":"2016","journal-title":"J Clin Cell Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2023.06.023_b0210","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00406-021-01237-z","article-title":"Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions","volume":"271","author":"North","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"issue":"6","key":"10.1016\/j.bbi.2023.06.023_b0215","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/15622975.2015.1062552","article-title":"High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance","volume":"16","author":"Noto","year":"2015","journal-title":"World J. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2023.06.023_b0220","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/schbul\/sbu099","article-title":"Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project","volume":"41","author":"Perkins","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2023.06.023_b0225","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbi.2021.07.009","article-title":"Associations of immunological proteins\/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample mendelian randomization study","volume":"97","author":"Perry","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.bbi.2023.06.023_b0230","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/schbul\/sby160","article-title":"A meta-analysis of immune parameters, variability, and assessment of modal distribution in psychosis and test of the immune subgroup hypothesis","volume":"45","author":"Pillinger","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2023.06.023_b0235","doi-asserted-by":"crossref","unstructured":"Purves-Tyson TD, Robinson K, Brown AM, et al. Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia. Frontiers in Immunology. 2020;11. Accessed February 16, 2022. https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02002.","DOI":"10.3389\/fimmu.2020.02002"},{"issue":"3","key":"10.1016\/j.bbi.2023.06.023_b0240","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","article-title":"The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity","volume":"20","author":"Randolph","year":"1998","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"7589","key":"10.1016\/j.bbi.2023.06.023_b0245","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbi.2023.06.023_b0250","article-title":"Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis","volume":"11","author":"Tamouza","year":"2021","journal-title":"Transl Psychiatry."},{"issue":"9","key":"10.1016\/j.bbi.2023.06.023_b0255","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1038\/s41380-020-01008-7","article-title":"Natural killer cells in first-episode psychosis: an innate immune signature?","volume":"26","author":"Tarantino","year":"2021","journal-title":"Mol Psychiatry."},{"issue":"1","key":"10.1016\/j.bbi.2023.06.023_b0260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.bbi.2023.06.023_b0265","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/schbul\/sbx109","article-title":"Widespread volumetric reductions in schizophrenia and schizoaffective patients displaying compromised cognitive abilities","volume":"44","author":"Van Rheenen","year":"2018","journal-title":"Schizophr Bull."},{"issue":"Pt B","key":"10.1016\/j.bbi.2023.06.023_b0270","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.neuroimage.2016.02.041","article-title":"HYDRA: revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework","volume":"145","author":"Varol","year":"2017","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.bbi.2023.06.023_b0275","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archpsyc.56.2.133","article-title":"Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study","volume":"56","author":"Velakoulis","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2023.06.023_b0280","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.63.2.139","article-title":"Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals","volume":"63","author":"Velakoulis","year":"2006","journal-title":"Arch Gen Psychiatry."},{"issue":"3","key":"10.1016\/j.bbi.2023.06.023_b0285","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/neu.2015.60","article-title":"Adjunctive use of interferon \u03b3 inducer for treatment of patients with schizophrenia","volume":"28","author":"Vetlugina","year":"2016","journal-title":"Acta Neuropsychiatr."},{"issue":"34","key":"10.1016\/j.bbi.2023.06.023_b0290","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9506","article-title":"Interferon-\u03b3 signaling in human iPSC\u2013derived neurons recapitulates neurodevelopmental disorder phenotypes","volume":"6","author":"Warre-Cornish","year":"2020","journal-title":"Sci Adv."},{"issue":"7","key":"10.1016\/j.bbi.2023.06.023_b0295","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1017\/S0033291721004815","article-title":"Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markers","volume":"53","author":"Watson","year":"2023","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.bbi.2023.06.023_b0300","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","article-title":"Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: a mendelian randomization study","volume":"79","author":"Williams","year":"2022","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2023.06.023_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146463","article-title":"Association of peripheral cytokine levels with cerebral structural abnormalities in schizophrenia","volume":"1724","author":"Wu","year":"2019","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.bbi.2023.06.023_b0310","doi-asserted-by":"crossref","first-page":"e982","DOI":"10.1038\/tp.2016.238","article-title":"Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation","volume":"6","author":"Zhang","year":"2016","journal-title":"Transl. Psychiatry."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123001678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123001678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:22:04Z","timestamp":1760170924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159123001678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":62,"alternative-id":["S0889159123001678"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2023.06.023","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneity","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2023.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}